Okay. Hang on just a second. I have a couple of – okay at Lloyd’s, we had – our losses there were about, I think, I said about $6 million in crop hail losses. And we had a few million dollars related to a couple of wind storm events during the quarter, which were not particularly large. So those were kind of the – really kind of the I think the major components of the increase in losses at Lloyd’s. And specialty, the biggest single group related to, I think, it was three aviation events, which all-in-all totaled a little over $10 million. And then we had some additional crop losses there as well of about $3 million I think – $3 million, yes.
Amit Kumar – Macquarie Research Equities: Okay, enough, that’s helpful. But the other question I had, I guess this goes back to Josh and Michael’s questions, regarding 2015. Recently, there has been some discussion in the market press that RenRe is either looking to or thinking about some sort of an agreement with one of the largest reinsurance brokers, if you will, to find outgrowth opportunities in the U.S. casualty reinsurance market. And I was trying to reconcile that fairly detailed discussion in the market press versus your comments. Could you sort of help us reconcile those comments versus your outlook for 2015, because net-net, it does seem like a meaningful departure as you start talking about casualty and lower tail businesses?
Kevin O’Donnell: Okay. Firstly, I think we have a great relationship with all our brokers and we look at them as all strategically important to us. The agreement that’s been discussed in the press is one that is not something that’s exclusive. There is no incentive payments for business, or anything else, it’s really much more around helping us to understand some different markets. It’s around helping us understand how those markets are placed into the reinsurance business and where they’re placed. So from that perspective, I think, it’s an agreement that we would gladly engage with any of our brokers. With regard to it being a departure from what we’ve done on the specialty side, we’ve been in the specialty business for a long time. We are continuing to build out what we think is a world-class platform between Bermuda, London, and the U.S. We have a great team, and we are applying the same discipline in the lines that we’re writing to the cat market that we’ve executed into for a long time. So I don’t feel as if it’s as different when I’m sitting in this seat, as potentially you’re suggesting it is. It feels very organic and very much natural to what we’ve always done.
Amit Kumar – Macquarie Research Equities: That answers my question. Thank you for that clarification. Thanks, and good luck for the future.
Kevin O’Donnell: I appreciate it. Thanks.